Cui Xiaotian, Zhao Jinzhao, Zhou Xinda, Hua Ang, Chengxi, Tan Chen, and Han Wei Liu Ping, a 25-year-old living in Beijing, is queuing up outside the obesity clinic of the Peking University People’s Hospital early one morning, seeking a doctor’s prescription for the so-called “skinny jab” — a weight loss drug that has created a buying frenzy in China, where half the adults out of a total population of 1.4 billion are either overweight or obese.
Related Posts
Ozempic, Wegovy, Mounjaro: Are GLP-1 drugs weight loss wonders or health gamble?
India, home to the world’s largest low- and middle-income (LMIC) population, is now facing a weighty challenge — literally. It…
This Ranjan Pai investment opens the door to a USD30 billion opportunity
Ranjan Pai is among India’s most influential investors. So, when he makes a move into senior care, it is time…
apollo: Apollo Hospitals: all bulked up for its next phase of expansion,yet conservative on acquisitions
Apollo Hospital in Mumbai, India. Synopsis Strong financial and operational performance marked the last five years, a consolidation phase for…
